Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans
Open Access
- 1 April 2009
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 75 (7), 736-745
- https://doi.org/10.1038/ki.2008.701
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN StudyAmerican Journal of Nephrology, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- TRPC6 and FSGS: The latest TRP channelopathyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Estimation of individual admixture: Analytical and study design considerationsGenetic Epidemiology, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- A High-Density Admixture Map for Disease Gene Discovery in African AmericansAmerican Journal of Human Genetics, 2004
- Renal Biopsy Findings in Presumed Hypertensive NephrosclerosisAmerican Journal of Nephrology, 1994
- Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.Hypertension, 1989
- Renal Insufficiency in Treated Essential HypertensionThe New England Journal of Medicine, 1989